+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heart Failure Drug"

Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Advanced Heart Failure - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Advanced Heart Failure - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Chronic Heart Failure - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Chronic Heart Failure - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Heart Failure - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Heart Failure - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Heart Failure - Epidemiology forecast- 2032 - Product Thumbnail Image

Heart Failure - Epidemiology forecast- 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Advanced Heart Failure - Epidemiology Forecast to 2032 - Product Thumbnail Image

Advanced Heart Failure - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Heart Failure - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Heart Failure - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute Heart failure (AHF) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Acute Heart failure (AHF) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Heart failure (HF) with Reduced Ejection Fraction (HFrEF) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Heart failure (HF) with Reduced Ejection Fraction (HFrEF) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Acute Heart failure (AHF) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acute Heart failure (AHF) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Heart failure (HF) with Reduced Ejection Fraction (HFrEF) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Heart failure (HF) with Reduced Ejection Fraction (HFrEF) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
BMS-986231 - Product Thumbnail Image

BMS-986231

  • Report
  • February 2018
  • 11 Pages
  • Global
From
Drug Analysis: BMS-986231 - Product Thumbnail Image

Drug Analysis: BMS-986231

  • Drug Pipelines
  • February 2018
  • 11 Pages
  • Global
From
Global Heart Failure Drugs Market 2021-2025 - Product Thumbnail Image

Global Heart Failure Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Global Prils Market 2022-2026 - Product Thumbnail Image

Global Prils Market 2022-2026

  • Report
  • January 2022
  • 120 Pages
  • Global
From
US Congestive Heart Failure Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Congestive Heart Failure Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Congestive Heart Failure Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Congestive Heart Failure Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Congestive Heart Failure Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Congestive Heart Failure Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Heart Failure (HF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Heart Failure (HF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • February 2023
  • 81 Pages
  • Global
From
Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • April 2022
  • 204 Pages
  • Global
From
Loading Indicator

The Heart Failure Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat a variety of heart-related conditions. Heart Failure Drugs are used to treat heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These drugs can help reduce symptoms, improve quality of life, and reduce the risk of death. Commonly used Heart Failure Drugs include ACE inhibitors, beta blockers, diuretics, and angiotensin receptor blockers. These drugs work by reducing the workload on the heart, improving blood flow, and reducing fluid buildup in the body. Some companies in the Heart Failure Drug market include Pfizer, Novartis, Merck, Sanofi, and Bristol-Myers Squibb. Show Less Read more